Idiopátiás tüdőfibrózis: vizsgálatok itt: Egyesült Államok
43 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleIdiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
- Where
- Anderson, Atlanta, Brandon, Chapel Hill, Cypress, DuBois, El Paso, Gastonia, Greensboro, Hannibal, Houston, Jacksonville, Kissimmee, Lakewood, Lexington, Loxahatchee Groves, Miami, Murray, New Orleans, Newport Beach, Palm Springs, Pensacola, Philadelphia, Redding, Reno, Richmond, Rochester, St. Petersburg, Tampa, The Bronx, Tulsa, Winston-Salem
- Életkor
- 40 év and over
- People
- 306
- Run by
- Trevi Therapeutics
See details and how to joinNCT07671911 · EU 2026-525877-38-00 - 3. fázisTaking peopleIdiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) Tablets
- Where
- Allen Park, Bend, Carrollton, Charlotte, Doral, Miami, Miami Lakes, New Britain, North Miami Beach, Portland, Rockville, Sugar Land, Tuscaloosa, Warren, Wilmington
- Életkor
- 40 év and over
- People
- 201
- Run by
- Trevi Therapeutics
See details and how to joinNCT07868419 - 2. fázisNot yet taking people in Egyesült ÁllamokA Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment
- Where
- Boston, Charleston, Cleveland, Dallas, DuBois, Durham, New Haven, Newport Beach, Palo Alto, Pensacola, Rochester, Salt Lake City, Tucson
- Életkor
- 40 év and over
- People
- 70 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07926321 · EU 2026-527098-13-00 - No phaseTaking peopleIdiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Where
- Ann Arbor, Atlanta, Aurora, Austell, Birmingham, Chapel Hill, Charleston, Charlottesville, Chicago, Cincinnati, Cleveland, Colchester, Columbus, Dallas, Detroit, Durham, Evanston, Falls Church, Gainesville, Greensboro, Hershey, Houston, Jackson, Kansas City, Lexington, Los Angeles, Maywood, Milwaukee, Minneapolis, Nashville, New Haven, New Orleans, New York, Oklahoma City, Philadelphia, Portland, Salt Lake City, Stanford, St Louis, Tampa, Tucson, Wilmington, Winston-Salem
- Életkor
- 21 év and over
- People
- 3000
- Run by
- Duke University
See details and how to joinNCT01915511 - 2. fázisTaking peopleA Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- Where
- Birmingham, Chapel Hill, Charleston, Chesterfield, Cincinnati, Denver, Detroit, El Paso, Houston, Indianapolis, Kansas City, Los Angeles, New Haven, New York, Salt Lake City, San Diego, Temple, Weston, Winston-Salem
- Életkor
- 40 év and over
- People
- 120 worldwide
- Run by
- Rein Therapeutics
See details and how to joinNCT06968845 · EU 2025-520715-13-00 - 2. fázisTaking peopleRE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Where
- Albuquerque, Ann Arbor, Atlanta, Aurora, Austin, Birmingham, Boston, Buffalo, Chapel Hill, Charlottesville, Chicago, Cleveland, Columbus, Draper, Honolulu, Kansas City, Knoxville, Madison, New York, Novi, Omaha, Philadelphia, Rockville, San Diego, Santa Rosa, Seattle, Shreveport, Tampa, Towson, Tucson, Worcester
- Életkor
- 18 év to 80 év
- People
- 100
- Run by
- Reunion Neuroscience Inc
See details and how to joinNCT07002034 - 2. fázisTaking peopleAn Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- Where
- Atlanta, Aurora, Baltimore, Bend, Birmingham, Charleston, Cincinnati, El Paso, Falls Church, Farmington, Hannibal, Houston, Kansas City, Los Angeles, Murray, Nashville, New Haven, Newport Beach, New York, Ocala, Philadelphia, Portland, Rochester, Salt Lake City, Seattle, Statesville, Winston-Salem
- Életkor
- 18 év and over
- People
- 340 worldwide
- Run by
- Avalyn Pharma Inc.
See details and how to joinNCT06951217 - 3. fázisTaking peopleA Study to Assess the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Progressive Pulmonary Fibrosis (PPF)
- Where
- DuBois
- Életkor
- 18 év to 85 év
- People
- 800
- Run by
- Insmed Incorporated
See details and how to joinNCT07805785 · EU 2026-525924-37-00 - 3. fázisNot yet taking people in Egyesült ÁllamokLong-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
- Where
- Birmingham, Ocala, Philadelphia
- Életkor
- 18 év and over
- People
- 2380 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00 - 2. fázisTaking peopleA Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Where
- Ann Arbor, Atlanta, Aurora, Baltimore, Birmingham, Boise, Boston, Burlington, Champaign, Charleston, Chicago, Cincinnati, Dallas, Denver, Detroit, El Paso, Fountain Hill, Greensboro, Houston, Kansas City, Lexington, Loma Linda, Los Angeles, Newport Beach, New York, Ocala, Oklahoma City, Philadelphia, Phoenix, Richmond, Sacramento, Stanford, Weston
- Életkor
- 40 év and over
- People
- 359 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07652658 - No phaseTaking peopleCollection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
- Where
- New York
- Életkor
- 18 év and over
- People
- 2000
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT01776398 - 3. fázisTaking peopleTrial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Where
- Cypress, Denison, DuBois, El Paso, Franklin, Greensboro, Hialeah, Kissimmee, Knoxville, North Dartmouth, Palm Spring, Redding, Reno, Rock Hill, The Woodlands, Webster
- Életkor
- 40 év and over
- People
- 1100 worldwide
- Run by
- PureTech
See details and how to joinNCT07284602 · EU 2025-524493-42-00 - 2. fázisNot yet taking people in Egyesült ÁllamokAutoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis
- Where
- Birmingham, Chapel Hill, Chicago, Kansas City, Philadelphia, Pittsburgh, Salt Lake City
- Életkor
- 40 év to 85 év
- People
- 52
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT07674745 - 3. fázisCsak meghívásosExtension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
- Where
- Albuquerque, Ann Arbor, Atlanta, Baltimore, Birmingham, Boston, Charleston, Charlottesville, Chesterfield, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Commack, Dallas, Denver, Durham, Falls Church, Franklin, Gainesville, Greensboro, Greenville, Hershey, Houston, Jackson, Jacksonville, Kansas City, Kissimmee, Knoxville, La Jolla, Los Angeles, Louisville, Madison, Maywood, McAllen, McKinney, Milwaukee, Minneapolis, Murray, Nashville, New Hyde Park, New Orleans, Newport Beach, New York, Oklahoma City, Omaha, Orlando, Philadelphia, Phoenix, Portland, Richmond, Rochester, Rock Hill, Royal Oak, Sacramento, Salt Lake City, San Francisco, Shreveport, Silver Spring, Stanford, St Louis, Tampa, The Bronx, The Woodlands, Tucson, Weston, Winston-Salem
- Életkor
- 40 év and over
- People
- 1850 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT04905693 - 2. fázisTaking peopleA Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
- Where
- Denison, Dothan, Hannibal, Hendersonville, Rock Hill, St. Petersburg
- Életkor
- 40 év and over
- People
- 240 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07516951 · EU 2024-514246-37-00 - 2. fázisTaking peopleStudy of ORJ-001 for the Treatment of IPF
- Where
- Doral, DuBois
- Életkor
- 40 év and over
- People
- 95
- Run by
- Oorja Bio, Inc.
See details and how to joinNCT07869147 - No phaseTaking peopleRemote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring
- Where
- San Francisco
- Életkor
- 18 év and over
- People
- 200
- Run by
- University of California, San Francisco
See details and how to joinNCT07673237 - No phaseTaking peoplePulmonary Fibrosis Foundation Community Registry
- Where
- Chicago
- Életkor
- 18 év and over
- People
- 10 000
- Run by
- Pulmonary Fibrosis Foundation
See details and how to joinNCT05382572 - 3. fázisNot yet taking people in Egyesült ÁllamokMetformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis
- Where
- Ann Arbor, Aurora, Boston, Chicago, Dallas, Houston, New York, Philadelphia, Rochester, Salt Lake City, Seattle, Tucson, Washington D.C., Worcester
- Életkor
- 40 év and over
- People
- 800
- Run by
- University of Massachusetts, Worcester
See details and how to joinNCT07520110 - 2. fázisTaking peopleStudy of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
- Where
- Ann Arbor, Birmingham, Champaign, Detroit, Dothan, Falls Church, Hannibal, Kissimmee, Philadelphia, Richmond
- Életkor
- 40 év and over
- People
- 165 worldwide
- Run by
- AbbVie
See details and how to joinNCT07230288 · EU 2024-518013-25-00 - 2. fázisTaking peopleOral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Where
- Bend, Chapel Hill, Chicago, Dallas, Denison, Dickson, Farmington, Indianapolis, Jacksonville, Kansas City, La Mesa, Louisville, Madison, Miami, New York, Philadelphia, Rochester, Royal Oak, San Francisco, Sioux Falls
- Életkor
- 40 év and over
- People
- 128
- Run by
- Cumberland Pharmaceuticals
See details and how to joinNCT05571059 - No phaseTaking peopleGenetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
- Where
- Pittsburgh
- Életkor
- 18 év and over
- People
- 2000
- Run by
- University of Pittsburgh
See details and how to joinNCT00258570 - No phaseTaking peopleGenomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
- Where
- Pittsburgh
- Életkor
- 18 év and over
- People
- 500
- Run by
- University of Pittsburgh
See details and how to joinNCT00373841 - No phaseTaking peoplePRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- Where
- Ann Arbor, Aurora, Charlottesville, Dallas, New York, Seattle, Worcester
- Életkor
- 18 év to 80 év
- People
- 500 worldwide
- Run by
- University of Massachusetts, Worcester
See details and how to joinNCT06855329 - 1. fázisTaking peopleMolecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
- Where
- Birmingham
- Életkor
- 40 év to 85 év
- People
- 10
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT04362644